Scellex
PrivateLast Round
Angel
Apr 1, 2024
Total Funding Raised
$54,000
Company Overview
Scellex operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a Grant round in June 2020.
Scellex is a discovery tools (healthcare) company that has developed a novel spatial gene sequencing technology intended to link microscope images to sequence data and provides RNA-seq services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scellex Comparables
Compare Scellex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resolve Biosciences | 85% | |
| Stellaromics | 81% | |
| OmicInsight Corporation | 78% |
For institutional investors. Book with your work email.
Scellex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Apr 1, 2024 | ||||
| Grant | Jun 25, 2020 | ||||
| Accelerator | Jun 8, 2020 |
For institutional investors. Book with your work email.
Scellex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Accelerator |
| Instrumentarium Science Foundation | Grant |
| Health Incubator Helsinki | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
Raised an Angel round with Jean de Gunzburg and Tuomas Tenkanen.
- Jun 25, 2020
$54K grant received from Instrumentarium Science Foundation.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 26, 2026
SCellex expands its RNA-seq service portfolio on Aug 26th '26 with FFPE-seq, which enables comprehensive gene expression analysis from FFPE tissues.
For institutional investors. Book with your work email.
Scellex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scellex's valuation, stock price, and market status.
Is Scellex a public or private company?
Scellex is a private company.
What is the current stock price of Scellex?
Scellex is a private company, so its shares have no public market price. Caplight tracks Scellex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scellex worth (valuation)?
Valuation information for Scellex is not publicly available.
Can I buy Scellex stock?
Scellex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scellex's last funding round?
Scellex's most recent funding round was Angel on April 1, 2024.
Who are the main investors in Scellex?
Key investors in Scellex include Business Finland, Instrumentarium Science Foundation, Health Incubator Helsinki.
Will Scellex IPO soon?
No public IPO plans have been announced for Scellex.
How can I track Scellex secondary market activity?
Caplight tracks bids, offers, and trades in Scellex's shares on secondary markets.